Announce Date | 05/06/2025 |
EPS Normalized Actual | $-1.14 (Miss by $-0.12) |
EPS GAAP Actual | $-1.14 (Miss by $-0.12) |
Revenue Actual | $0.028B |
Revenue Surprise | Beat by $28M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 0.69333 | 13.46 | 0.30513 | 1.87613 | 2 |
Dec 2027 | -2.8025 | -3.33 | -7.58348 | -1.23336 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -1.14 | -1.14 | 0.028B | -417.86% | 28M |
FQ4 2024 (Dec 2024) | 0 | 0 | 0.026B | -19.23% | 26M |
FQ3 2024 (Sep 2024) | -1.01 | -1.01 | 0.048B | 33.33% | 48M |
FQ2 2024 (Jun 2024) | -1.02 | -1.02 | 0.039B | 25.64% | 39M |
FQ1 2024 (Mar 2024) | -0.0464 | -0.0464 | 0.145B | 82.76% | 145M |
FQ4 2023 (Dec 2023) | -1.09 | -1.09 | 0.031B | -8.56% | 31M |
FQ3 2023 (Sep 2023) | -0.95 | -0.95 | 0.032B | -4.94% | 32M |
FQ2 2023 (Jun 2023) | -1.02 | -1.02 | 0.029B | 7.73% | 29M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2029 (Dec 2029) | 0 | -- | 0 | 0 | 0 |
FQ3 2029 (Sep 2029) | 0 | -- | 0 | 0 | 0 |
FQ2 2029 (Jun 2029) | 1.3133 | -- | 0.90532 | 1.94476 | 1 |
FQ1 2029 (Mar 2029) | 1.0319 | -- | 0.71134 | 1.52806 | 1 |
FQ4 2028 (Oct 2028) | 0.5941 | -- | 0.1392 | 1.54888 | 2 |
FQ3 2028 (Jul 2028) | 0.3784 | -- | 0.08866255 | 0.98653 | 2 |
FQ2 2028 (Jun 2028) | 0.3784 | -- | 0.11447 | 0.87442 | 2 |
FQ1 2028 (Mar 2028) | 0.2013 | -- | 0.06089379 | 0.46517 | 2 |
FQ4 2027 (Oct 2027) | -0.1438 | -- | -0.3749 | -0.03369364 | 1 |
FQ3 2027 (Jul 2027) | -0.3578 | -- | -0.93282 | -0.08383578 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2029 (Dec 2029) | 0.51B | -- | 0.38B | 0.65B | 1 |
FQ3 2029 (Sep 2029) | 0.43B | -- | 0.33B | 0.59B | 1 |
FQ2 2029 (Jun 2029) | 0.38B | -- | 0.29B | 0.51B | 1 |
FQ1 2029 (Mar 2029) | 0.32B | -- | 0.25B | 0.44B | 1 |
FQ4 2028 (Oct 2028) | 0.22B | -- | 0.09B | 0.5B | 1 |
FQ3 2028 (Jul 2028) | 0.19B | -- | 0.08B | 0.43B | 1 |
FQ2 2028 (Jun 2028) | 0.19B | -- | 0.09B | 0.38B | 1 |
FQ1 2028 (Mar 2028) | 0.16B | -- | 0.08B | 0.33B | 1 |
FQ4 2027 (Oct 2027) | 0.11B | -- | 0.05B | 0.26B | 2 |
FQ3 2027 (Jul 2027) | 0.09B | -- | 0.04B | 0.19B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
7
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -1.14 | -1.14 | 100% | |
FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
FQ3 2024 (Sep 2024) | -1.01 | -1.01 | 100% | |
FQ2 2024 (Jun 2024) | -1.02 | -1.02 | 100% | |
FQ1 2024 (Mar 2024) | -0.0464 | -0.0464 | 100% | |
FQ4 2023 (Dec 2023) | -1.09 | -1.09 | 100% | |
FQ3 2023 (Sep 2023) | -0.95 | -0.95 | 100% | |
FQ2 2023 (Jun 2023) | -1.02 | -1.02 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $0.03B | $28M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.03B | $26M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.05B | $48M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.04B | $39M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.15B | $145M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.03B | $31M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.03B | $32M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.03B | $29M | 100% |